← positive_eps_streak (all companies) · EBS (all signals) · all methodology

positive_eps_streak on Emergent BioSolutions Inc. (EBS)

SIC 2834 — Pharmaceutical Preparations · CIK 1367644 · default direction: long

Definition

Fires on companies with consecutive years of positive earnings — quality compounder candidates. Surfaces stable franchises with earnings durability, not speculative growth.

Every time the signal fired on EBS

FYFiling dateEvent date1d5d20d60d252d
FY20212022-02-252022-02-25+4.39%+4.92%+11.50%-7.49%-68.77%
FY20202021-02-192021-02-19-5.14%-6.83%-11.70%-41.49%-58.79%
FY20192020-02-252020-02-25-2.49%-6.43%-6.66%+47.87%+64.91%
FY20182019-02-222019-02-22-3.66%-6.03%-23.69%-31.63%-2.98%
FY20172018-02-232018-02-23+3.05%+3.11%+9.92%+7.12%+20.37%
FY20162017-02-282017-02-28+1.12%-2.04%-8.09%-3.54%+58.38%
FY20152016-02-292016-02-29+3.81%+5.17%+5.00%+25.13%-7.24%
FY20142015-03-092015-03-09-0.03%+2.24%-0.62%+10.48%+19.31%
FY20132014-03-102014-03-10-3.35%-3.77%-13.63%-23.64%+3.20%
FY20122013-03-082013-03-08-5.29%-3.36%-14.78%-8.33%+81.34%

Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.

Universe-wide calibration (this signal across all companies)

Horizonn eventsGross stock retHit rateTrade dirNet PnLCost (bps)r/σ net
1d21,256+0.05%+49.53%long-0.16%22-0.04
5d21,258+0.10%+50.10%long-0.10%22-0.00
20d21,218-0.80%+49.80%long-1.03%22-0.04
60d19,852+1.64%+54.15%long+1.48%22+0.04
252d19,501+13.65%+64.44%long+13.47%22+0.27

Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See positive_eps_streak methodology for the full audit.


Data: /api/company/1367644/financials